In comparison with IL-15+biNV, biNV-IL-15 suppressed the development of cancer metastasis much more effectively, achieving synergistic therapeutic outcomes of spatiotemporally synchronous provision of IL-15 and tumor antigen to CD8+ T cells. This evidence concerns the gene CD8A and neoplasm.